Tag Archives: vrx

Valeant, Jazz Among IBD 50 Stocks Earnings This Week

With earnings season winding down, only a handful of leading stocks have yet to report results, but Valeant Pharmaceuticals (VRX) and Jazz Pharmaceuticals (JAZZ) could give investors a late-season lift. Jazz, Valeant and Amira Nature Foods (ANFI) are the IBD 50 stocks set to provide quarterly results this week. Jazz is No. 4 on the IBD 50 and is on tap to report financials Tuesday. It’s grown in part by buying other drugmakers. Wall Street liked

Valeant To Buy PreCision Dermatology For $475 Million

Valeant Pharmaceuticals (VRX) on Monday announced a deal to acquire PreCision Dermatology for $475 million in cash, sending Valeant stock lower. The deal is expected to close in the first half of the year, and Valeant will pay an extra $25 million if PreCision hits a “sales-based milestone,” Valeant said in a press release. Shares of Valeant, one of Canada’s biggest drugmakers, dipped about 2% on the stock market today. Cumberland, R.I.-based